Financial reimbursement incentives in the use of biosimilars for rheumatoid arthritis in Japan
Background Biosimilars present a significant opportunity for cost savings. However, the uptake of biosimilars has been inconsistent across different regions and drugs, highlighting the need for effective policy interventions. This study aimed to investigate the impact of Japan's reimbursement incent...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Taylor & Francis Group
2026-12-01
|
| Ráidu: | Journal of Pharmaceutical Policy and Practice |
| Fáttát: | |
| Liŋkkat: | https://www.tandfonline.com/doi/10.1080/20523211.2026.2633832 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|